0001213900-20-012443.txt : 20200515 0001213900-20-012443.hdr.sgml : 20200515 20200515103854 ACCESSION NUMBER: 0001213900-20-012443 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 ITEM INFORMATION: Other Events FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOQI International Medical, Inc. CENTRAL INDEX KEY: 0001213660 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FABRICATED METAL PRODUCTS [3490] IRS NUMBER: 020563302 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34890 FILM NUMBER: 20881780 BUSINESS ADDRESS: STREET 1: ROOM 3601, BUILDING A, HARBOUR VIEW PL STREET 2: NO 2 WUWU ROAD,ZHONGSHAN DISTRICT DALIAN CITY: LIAONING PROVINCE, P. R. STATE: F4 ZIP: 116000 BUSINESS PHONE: (8604) 1182209211 MAIL ADDRESS: STREET 1: ROOM 3601, BUILDING A, HARBOUR VIEW PL STREET 2: NO 2 WUWU ROAD,ZHONGSHAN DISTRICT DALIAN CITY: LIAONING PROVINCE, P. R. STATE: F4 ZIP: 116000 FORMER COMPANY: FORMER CONFORMED NAME: NF Energy Saving Corp DATE OF NAME CHANGE: 20090825 FORMER COMPANY: FORMER CONFORMED NAME: NF Energy Saving CORP of America DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: Diagnostic CORP of America DATE OF NAME CHANGE: 20041115 8-K 1 ea121889-8k_boqiintl.htm CURRENT REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

May 15, 2020

Date of Report

 

(Date of earliest event reported)

 

BOQI International Medical Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   000-50155   02-0563302
(State or other jurisdiction
of incorporation)		  

(Commission

File Number)

   (IRS Employer
Identification No.)

 

Room 3601, Building A, Harbour View Place, No. 2 Wuwu Road,
Zhongshan District, Dalian, Liaoning Province, P. R. China, 116000

(Address of principal executive offices and zip code)
 
(8604) 1182209211
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.001 par value   BIMI   The NASDAQ Capital Market

 

 

ITEM 8.01 OTHER EVENTS

 

BOQI International Medical Inc. (the “Company”) will be relying on the Securities and Exchange Commission’s Order under Section 36 of the Securities Exchange Act of 1934 Granting Exemptions From Specified Provisions of the Exchange Act and Certain Rules Thereunder dated March 25, 2020 (Release No. 34-88465) (the “Order”) to delay the filing of its Quarterly Report on Form 10-Q for the three months ended March 31, 2020 (the “Report”) due to the circumstances related to COVID-19. In particular, COVID-19 has caused disruptions in the Company’s day-to-day operations resulting in limited access to the Company’s facilities and limited support from its staff and professional advisors. This has, in turn, delayed the Company’s ability to complete the Report. Notwithstanding the foregoing, the Company expects to file the Report no later than June 29, 2020 (which is 45 days from the Report’s original filing deadline of May 15, 2020).

 

You should carefully consider the risk factors discussed in Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, including the risk factor captioned “The recent COVID-19 pandemic had a material adverse effect on our business operations, results of operations, cash flows and financial position” and the discussion relating to the impact of COVID-19 on our operations in Part I Item 7 ”Management’s Discussion and Analysis of Financial Condition and Results of Operations” in such Annual Report.

 

1
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: May 15, 2020 BOQI International Medical Inc.
  (Registrant)
     
  By: /s/ Tiewei Song
    Tiewei Song
    Chief Executive Officer

 

2